Literature DB >> 10102682

DNA demethylation during the differentiation of 3T3-L1 cells affects the expression of the mouse GLUT4 gene.

N Yokomori1, M Tawata, T Onaya.   

Abstract

GLUT4 is the major glucose transporter in adipose tissue and skeletal and cardiac muscles. We examined the mechanisms underlying GLUT4 gene expression in 3T3-L1 cells, which express the gene during their differentiation from preadipocytes to adipocytes. In transient transfections, the activity of a mouse GLUT4 promoter extending to -100 bp in the 5'-flanking region did not differ significantly between 3T3-L1 preadipocytes and adipocytes. Promoter activity up to -590 bp in preadipocytes and adipocytes showed a 70% lower and 228% higher activity, respectively, than promoter activity extending to -100 bp. We also examined methylation status of the GLUT4 promoter. Up to -100 bp, there were five CpG sites at -11, -30, -58, -63, and -75 bp. Two CpG sites at -11 and -30 bp were highly methylated in preadipocytes (60 and 92%, respectively) and highly demethylated in adipocytes (28.6 and 25%, respectively). Conversely, three CpG sites at -58, -63, and -75 bp were highly demethylated in both preadipocytes and adipocytes (<12%). In gel mobility-shift assays, a fragment extending from -40 to -1 bp generated a methylation-sensitive band with nuclear extracts from both preadipocytes and adipocytes when the CpG sites were methylated. Southwestern analysis identified a protein of approximately 55 kDa that bound strongly to the methylated probe. Furthermore, methylation of the CpG sites inhibited promoters extending to -50 or -70 bp. These results suggest that in addition to cell type-specific transcription factor, methylation of specific CpG sites and the methylation-sensitive transcription factor contribute to GLUT4 gene regulation during 3T3-L1 differentiation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10102682     DOI: 10.2337/diabetes.48.4.685

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  38 in total

1.  Developmental programming of the metabolic syndrome - critical windows for intervention.

Authors:  Mark H Vickers
Journal:  World J Diabetes       Date:  2011-09-15

Review 2.  Metabolic programming in the pathogenesis of insulin resistance.

Authors:  Sherin U Devaskar; Manikkavasagar Thamotharan
Journal:  Rev Endocr Metab Disord       Date:  2007-06       Impact factor: 6.514

Review 3.  Epigenetic reprogramming and imprinting in origins of disease.

Authors:  Wan-yee Tang; Shuk-mei Ho
Journal:  Rev Endocr Metab Disord       Date:  2007-06       Impact factor: 6.514

Review 4.  Epigenomics, gestational programming and risk of metabolic syndrome.

Authors:  M Desai; J K Jellyman; M G Ross
Journal:  Int J Obes (Lond)       Date:  2015-02-02       Impact factor: 5.095

5.  Epigenetic regulation of glucose transporter 4 by estrogen receptor β.

Authors:  Joëlle Rüegg; Wen Cai; Mohsen Karimi; Nimrod B Kiss; Elin Swedenborg; Catharina Larsson; Tomas J Ekström; Ingemar Pongratz
Journal:  Mol Endocrinol       Date:  2011-10-20

6.  Global DNA methylation levels in human adipose tissue are related to fat distribution and glucose homeostasis.

Authors:  Maria Keller; Susan Kralisch; Kerstin Rohde; Dorit Schleinitz; Arne Dietrich; Michael R Schön; Daniel Gärtner; Tobias Lohmann; Miriam Dreßler; Anke Tönjes; Michael Stumvoll; Peter Kovacs; Mathias Fasshauer; Matthias Blüher; Yvonne Böttcher
Journal:  Diabetologia       Date:  2014-08-22       Impact factor: 10.122

Review 7.  Epigenetic Regulation of the Thermogenic Adipose Program.

Authors:  Audrey Sambeat; Olga Gulyaeva; Jon Dempersmier; Hei Sook Sul
Journal:  Trends Endocrinol Metab       Date:  2016-09-28       Impact factor: 12.015

8.  Regulation of cyclin D1 and Wnt10b gene expression by cAMP-responsive element-binding protein during early adipogenesis involves differential promoter methylation.

Authors:  Keith E Fox; Lillester A Colton; Paul F Erickson; Jacob E Friedman; Hyuk C Cha; Pernille Keller; Ormond A MacDougald; Dwight J Klemm
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

9.  Type 2 Diabetes Genetics: Beyond GWAS.

Authors:  Dharambir K Sanghera; Piers R Blackett
Journal:  J Diabetes Metab       Date:  2012-06-23

10.  Role of Ucp1 enhancer methylation and chromatin remodelling in the control of Ucp1 expression in murine adipose tissue.

Authors:  A Shore; A Karamitri; P Kemp; J R Speakman; M A Lomax
Journal:  Diabetologia       Date:  2010-03-18       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.